![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Foundation Medicine FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Foundation Medicine](http://mms.businesswire.com/media/20171130006320/en/627349/4/FMI_Exterior_for_Press_Kit.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Foundation Medicine
![Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire](https://mms.businesswire.com/media/20180923005029/en/627351/23/FMI_lockup%C2%AE_left_fire_RGB300ppi_For_BW.jpg)
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company's Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer | Business Wire
![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire](https://mms.businesswire.com/media/20171130006320/en/627351/5/FMI_lockup%C2%AE_left_fire_RGB300ppi_For_BW.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
![a The Foundation One report of the patient. b Sensitivity test results... | Download Scientific Diagram a The Foundation One report of the patient. b Sensitivity test results... | Download Scientific Diagram](https://www.researchgate.net/publication/339038165/figure/fig1/AS:863949809541120@1582993094342/a-The-Foundation-One-report-of-the-patient-b-Sensitivity-test-results-with-the-M-score_Q640.jpg)
a The Foundation One report of the patient. b Sensitivity test results... | Download Scientific Diagram
![profiling results from FoundationOne™ testing. 73 deleterious mutations... | Download Scientific Diagram profiling results from FoundationOne™ testing. 73 deleterious mutations... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Castro-3/publication/286403721/figure/tbl1/AS:613937913528376@1523385613971/profiling-results-from-FoundationOne-testing-73-deleterious-mutations-were-identified_Q640.jpg)
profiling results from FoundationOne™ testing. 73 deleterious mutations... | Download Scientific Diagram
![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire](https://mms.businesswire.com/media/20171130006320/en/627350/4/Lab_Image_for_Press_Kit.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
![Survey of Precision Oncology Programs Finds Agreement on Testing, Divergence in Care Delivery | Precision Oncology News Survey of Precision Oncology Programs Finds Agreement on Testing, Divergence in Care Delivery | Precision Oncology News](https://www.precisiononcologynews.com/sites/default/files/newspics/chart1.png)
Survey of Precision Oncology Programs Finds Agreement on Testing, Divergence in Care Delivery | Precision Oncology News
![Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience](https://www.frontiersin.org/files/Articles/687730/fonc-11-687730-HTML/image_m/fonc-11-687730-t001.jpg)
Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience
![Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience](https://www.frontiersin.org/files/MyHome%20Article%20Library/687730/687730_Thumb_400.jpg)